CLIMB Act, DOJ Rescheduling Delays & Medicare’s Full-Spectrum CBD Rules | Cannabis Legalization News

Send us Fan MailTom hosts another episode of Cannabis Legalization News, recapping the week’s major policy and market developments. The show covers the newly introduced bipartisan CLIMB Act (Capital Lending and Investment for Marijuana Businesses Act), which would provide safe harbor for U.S. stock exchanges and market participants to list and trade cannabis-related securities. They discuss reports that “Pot Inc.” is poised to benefit from President Trump’s marijuana reclassification directive, but that DOJ—under Pam Bondi—has no deadline and is still working through a complicated internal process, while rescheduling alone won’t create a full regulatory framework. The episode also reviews CMS/Medicare guidance moving toward coverage of certain hemp-derived full-spectrum CBD edibles with strict limits (under 3 mg THC per serving, later tightening), benefiting companies like Charlotte’s Web. Additional topics include a CRS rescheduling update, state-level restrictions, Virginia adult-use timing, dispensary build-out/financing realities, and cannabis marketing limits.00:00 Welcome and Week Ahead02:01 Climb Act Wall Street Access03:50 Politics Gas and Gripes05:06 Trump Reclassification Watch06:55 CMS Hemp CBD Rules09:35 Charlotte's Web Stock Surge12:41 CRS Rescheduling Update16:42 State Markets and Homegrow20:46 DEA Data Youth Use Down22:45 State Legislation Virginia Focus26:40 Ballot Rules Block Legalization28:13 Verano Loan Breakdown29:54 Building a Brand Lounge31:09 Amazon Style Ad Revenue32:08 Regulatory Steps and Loans32:44 Wisconsin Hemp Guardrails33:54 Why Dispensaries Take Years37:43 Strain Talk Ridgeline Runtz39:18 AI Tools and Weed Blog42:08 Interstate Commerce and Branding45:15 Pricing Menus and Market Fit46:53 Missouri Expansion and Exit Strategy48:36 Wrap Up and Legal SponsorSupport the showGet our newsletter: https://bit.ly/3VEn9vu